Mechanisms of resistance to pi3k inhibitors in cancer: Adaptive responses, drug tolerance and cellular plasticity
10.3390/cancers13071538
Saved in:
Main Authors: | Wright, Sarah Christine Elisabeth, Vasilevski, Natali, Serra, Violeta, Rodon, Jordi, Eichhorn, Pieter Johan Adam |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Review |
Published: |
MDPI AG
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/232812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER
by: DANIEL TAN SHAO WENG
Published: (2017) -
Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors
by: Zhang, C., et al.
Published: (2014) -
Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy
by: Tan, J., et al.
Published: (2014) -
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
by: Glaviano, A, et al.
Published: (2023) -
Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: Meta-analysis, co-occurrence and ethnic variation
by: Chong, M.-L., et al.
Published: (2014)